Murepavadin TFA
CAS No. ——
Murepavadin TFA ( POL7080 TFA )
Catalog No. M29749 CAS No. ——
Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameMurepavadin TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionMurepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
-
DescriptionMurepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
-
In Vitro——
-
In Vivo——
-
SynonymsPOL7080 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorP. aeruginosa
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1667.83
-
Molecular FormulaC73H112N22O16.C2HF3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Cyclo(Ala-Ser-{d-Pro}-Pro-Thr-Trp-Ile-{Dab}-{Orn}-{d-Dab}-{Dab}-Trp-{Dab}-{Dab})
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Matteo Bassetti, et al. New antibiotics for ventilator-associated pneumonia. Curr Opin Infect Dis. 2018 Jan 13.
molnova catalog
related products
-
6-O-acetylsaikosapon...
6''-O-acetylsaikosaponin A is an acetyl saikosaponin isolated from the roots of Bupleurum chinense. Itshows some osteoclast-inhibiting activities.
-
7-keto-deoxycholic a...
7-keto-deoxycholic acid is converted from Lactobacillus and Bifidobacterium with specific condition and from cholic acid in vitro.
-
Ibrolipim
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.